-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MhcA4TE2mqqZXkeGcPmZyFUZOdOAPWqdD+zBQmYwtWYG+0jhvcpj+mEVSPSC0mVY UrEJZtFVbtMBvzcJlY722g== 0001181431-09-046988.txt : 20091006 0001181431-09-046988.hdr.sgml : 20091006 20091006162638 ACCESSION NUMBER: 0001181431-09-046988 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091002 FILED AS OF DATE: 20091006 DATE AS OF CHANGE: 20091006 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Evoniuk Perry CENTRAL INDEX KEY: 0001455188 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26137 FILM NUMBER: 091108272 MAIL ADDRESS: STREET 1: 3029 29TH AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98199 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DRUGSTORE COM INC CENTRAL INDEX KEY: 0001086467 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 043416255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 411 108TH AVE. NE STREET 2: SUITE 1400 CITY: BELLEVUE STATE: WA ZIP: 98004 BUSINESS PHONE: 4253723200 MAIL ADDRESS: STREET 1: 411 108TH AVE. NE STREET 2: SUITE 1400 CITY: BELLEVUE STATE: WA ZIP: 98004 4 1 rrd252397.xml RSA & SSAR GRANT 10.02.09 X0303 4 2009-10-02 0 0001086467 DRUGSTORE COM INC DSCM 0001455188 Evoniuk Perry 411 108TH AVE NE SUITE 1400 BELLEVUE WA 98004 0 1 0 0 VP, Enterprise Architecture Common Stock 2009-10-02 4 A 0 8714 0.00 A 98321 D Stock-Settled Stock Appreciation Rights 2.28 2009-10-02 5 A 0 74691 0.00 A 2009-10-02 2019-10-02 Common Stock 74691 74691 D 2008 Equity Incentive Plan restricted stock award. Indicates vesting commencement date; the stock-settled stock appreciation rights ("SSARs") become exercisable as to the SSARs'original share total over 48 months, at the rate of 20% six months from the vesting commencement date and the remaining 80% vesting in equal increments at the end of each quarterly period thereafter. /s/ Perry R Evoniuk 2009-10-06 -----END PRIVACY-ENHANCED MESSAGE-----